Journal of Clinical and Translational Hepatology

Papers
(The H4-Index of Journal of Clinical and Translational Hepatology is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Metabolic-associated Fatty Liver Disease (MAFLD): A Multi-systemic Disease Beyond the Liver69
Reactive Oxygen Species and Oxidative Stress in the Pathogenesis of MAFLD39
Statin-induced Liver Injury Patterns: A Clinical Review30
Comparing the Diagnostic Criteria of MAFLD and NAFLD in the Chinese Population: A Population-based Prospective Cohort Study30
Treatments of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: Current Status and Controversy22
Persistently Rising Alpha-fetoprotein in the Diagnosis of Hepatocellular Carcinoma: A Review22
Acute Hepatitis of Unknown Origin in Children: Early Observations from the 2022 Outbreak22
Ginsenoside Rb1 Reduces D-GalN/LPS-induced Acute Liver Injury by Regulating TLR4/NF-κB Signaling and NLRP3 Inflammasome21
Coagulation and Endothelial Dysfunction Associated with NAFLD: Current Status and Therapeutic Implications20
Role of Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma19
Overexpression of Hepcidin Alleviates Steatohepatitis and Fibrosis in a Diet-induced Nonalcoholic Steatohepatitis17
Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022)17
Metabolic Dysfunction-associated Fatty Liver Disease is Associated with Greater Impairment of Lung Function than Nonalcoholic Fatty Liver Disease17
Drugs for Non-alcoholic Steatohepatitis (NASH): Quest for the Holy Grail17
Biomarkers of Metabolic (Dysfunction)-associated Fatty Liver Disease: An Update16
Epidemiology and Clinical Outcomes of Metabolic (Dysfunction)-associated Fatty Liver Disease16
0.039170026779175